EcoDrugPlus

Retinoic Acid Receptor Beta

Ensembl ID : ENSLOCG00000006890
Gene Symbol: RARB
4 Cross references
450 Possible Orthologues:

Retinoic Acid Receptor Gamma

Ensembl ID : ENSLOCG00000006240
Gene Symbol: RARG
3 Cross references
426 Possible Orthologues:

Retinoid X Receptor Alpha

Ensembl ID : ENSLOCG00000004579
Gene Symbol: RXRA
3 Cross references
246 Possible Orthologues:

Rho-Associated, Coiled-Coil Containing Protein Kinase 2b

Ensembl ID : ENSLOCG00000016666
Gene Symbol: ROCK2B
1 Cross references
305 Possible Orthologues:

Ribosomal Protein L10

Ensembl ID : ENSLOCG00000015500
Gene Symbol: RPL10
3 Cross references
410 Possible Orthologues:

Ribosomal Protein L10a

Ensembl ID : ENSLOCG00000000533
Gene Symbol: RPL10A
3 Cross references
367 Possible Orthologues:

Ribosomal Protein L11

Ensembl ID : ENSLOCG00000000953
Gene Symbol: RPL11
3 Cross references
288 Possible Orthologues:

Ribosomal Protein L13

Ensembl ID : ENSLOCG00000004063
Gene Symbol: RPL13
3 Cross references
275 Possible Orthologues:

Ribosomal Protein L13a

Ensembl ID : ENSLOCG00000004388
Gene Symbol: RPL13A
3 Cross references
369 Possible Orthologues:

Ribosomal Protein L14

Ensembl ID : ENSLOCG00000001044
Gene Symbol: RPL14
1 Cross references
309 Possible Orthologues:

Ribosomal Protein L15

Ensembl ID : ENSLOCG00000006808
Gene Symbol: RPL15
3 Cross references
357 Possible Orthologues:

Ribosomal Protein L17

Ensembl ID : ENSLOCG00000012148
Gene Symbol: RPL17
3 Cross references
711 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).